⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZVRA News
Zevra Therapeutics, Inc. Common Stock
ZVRA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Zevra Therapeutics (ZVRA)
businesswire.com
ZVRA
ZVRA Investor Alert: Levi & Korsinsky Investigates Zevra Therapeutics, Inc. (ZVRA) For Potential Securities Fraud
accessnewswire.com
ZVRA
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zevra Therapeutics, Inc. (ZVRA) And Encourages Stockholders to Connect
accessnewswire.com
ZVRA
Zevra Therapeutics, Inc. (ZVRA) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
ZVRA
ZVRA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zevra Therapeutics
prnewswire.com
ZVRA
ZVRA Investors Have Opportunity to Join Zevra Therapeutics, Inc. Fraud Investigation with SBS Law
businesswire.com
ZVRA
Zevra Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zevra Therapeutics (ZVRA)
prnewswire.com
ZVRA
Zevra Therapeutics, Inc. (ZVRA) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
ZVRA
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
globenewswire.com
ZVRA
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
globenewswire.com
ZVRA